1. Home
  2. JMSB vs GLSI Comparison

JMSB vs GLSI Comparison

Compare JMSB & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Marshall Bancorp Inc.

JMSB

John Marshall Bancorp Inc.

HOLD

Current Price

$22.27

Market Cap

308.2M

Sector

Finance

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$17.05

Market Cap

272.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMSB
GLSI
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.2M
272.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
JMSB
GLSI
Price
$22.27
$17.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$23.00
$50.00
AVG Volume (30 Days)
54.2K
138.7K
Earning Date
04-29-2026
05-19-2026
Dividend Yield
1.72%
N/A
EPS Growth
24.17
N/A
EPS
0.43
N/A
Revenue
N/A
N/A
Revenue This Year
$17.09
N/A
Revenue Next Year
$10.03
N/A
P/E Ratio
$53.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.02
$7.78
52 Week High
$23.28
$34.10

Technical Indicators

Market Signals
Indicator
JMSB
GLSI
Relative Strength Index (RSI) 52.92 34.86
Support Level $20.66 $8.19
Resistance Level $22.10 $29.89
Average True Range (ATR) 0.91 1.98
MACD 0.01 -0.20
Stochastic Oscillator 46.25 7.77

Price Performance

Historical Comparison
JMSB
GLSI

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: